支链氨基酸在心血管疾病中的研究进展
Research Progress of Branched-Chain Amino Acids in Cardiovascular Diseases
DOI: 10.12677/jcpm.2026.51064, PDF,    科研立项经费支持
作者: 朱浩然, 张亚茹, 崔 璐, 张 爽, 杨鹏飞, 明芙蓉:济宁医学院临床医学院(附属医院),山东 济宁;济宁医学院附属医院心内科冠心病二病区,山东 济宁;尹晓荣:济宁医学院附属医院心内科冠心病二病区,山东 济宁;申 程*:济宁医学院附属医院心内科冠心病二病区,山东 济宁;山东省医药卫生心血管病学重点学科(济宁医学院附属医院),山东 济宁;山东省医药卫生心血管疾病诊疗重点实验室(济宁医学院附属医院),山东 济宁;济宁市冠脉介入精准治疗研究重点实验室,山东 济宁
关键词: 支链氨基酸心血管疾病代谢Branched-Chain Amino Acids Cardiovascular Diseases Metabolism
摘要: 支链氨基酸(Branched-chain amino acid, BCAA)作为必需氨基酸,不仅是蛋白质合成的基本单元,还作为重要的信号分子参与机体多种生理和病理过程。近年来,越来越多的证据表明,BCAA代谢紊乱与心血管疾病的发生发展密切相关。BCAA代谢通路中关键酶的缺陷可导致其在体内异常累积,通过激活哺乳动物雷帕霉素靶蛋白(mammalian target of rapamycin, mTOR)信号通路、影响能量代谢、加剧氧化应激等多种机制,促进高血压病、冠心病、心力衰竭、心律失常等疾病的进展。本文就BCAA及其代谢产物在多种心血管疾病中的作用及分子机制研究进展进行综述。
Abstract: Branched-chain amino acid (BCAA) is essential amino acids that serve not only as fundamental building blocks for protein synthesis but also as important signaling molecules involved in various physiological and pathological processes. In recent years, accumulating evidence has demonstrated that dysregulation of BCAA metabolism is closely associated with the development and progression of cardiovascular diseases. Deficiencies or dysfunctions of key enzymes in the BCAA metabolic pathway can lead to abnormal accumulation of BCAA and their metabolites, thereby promoting cardiovascular pathology through multiple mechanisms, including activation of the mammalian target of rapamycin (mTOR) signaling pathway, disruption of energy metabolism, and exacerbation of oxidative stress. These metabolic disturbances have been implicated in the progression of hypertension, coronary artery disease, heart failure, arrhythmias, and other cardiovascular disorders. This review summarizes the current advances in understanding the roles of BCAA and their metabolic products in cardiovascular diseases, with a particular focus on the underlying molecular mechanisms.
文章引用:朱浩然, 张亚茹, 尹晓荣, 崔璐, 张爽, 杨鹏飞, 明芙蓉, 申程. 支链氨基酸在心血管疾病中的研究进展[J]. 临床个性化医学, 2026, 5(1): 460-467. https://doi.org/10.12677/jcpm.2026.51064

参考文献

[1] Neinast, M., Murashige, D. and Arany, Z. (2019) Branched Chain Amino Acids. Annual Review of Physiology, 81, 139-164. [Google Scholar] [CrossRef] [PubMed]
[2] Gedi, V. and Yoon, M. (2012) Bacterial Acetohydroxyacid Synthase and Its Inhibitors—A Summary of Their Structure, Biological Activity and Current Status. The FEBS Journal, 279, 946-963. [Google Scholar] [CrossRef] [PubMed]
[3] Liang, Y., Long, Z., Zhang, Y., Luo, C., Yan, L., Gao, W., et al. (2021) The Chemical Mechanisms of the Enzymes in the Branched-Chain Amino Acids Biosynthetic Pathway and Their Applications. Biochimie, 184, 72-87. [Google Scholar] [CrossRef] [PubMed]
[4] Goldsborough, E., Tasdighi, E. and Blaha, M.J. (2023) Assessment of Cardiovascular Disease Risk: A 2023 Update. Current Opinion in Lipidology, 34, 162-173. [Google Scholar] [CrossRef] [PubMed]
[5] Vaduganathan, M., Mensah, G.A., Turco, J.V., Fuster, V. and Roth, G.A. (2022) The Global Burden of Cardiovascular Diseases and Risk: A Compass for Future Health. Journal of the American College of Cardiology, 80, 2361-2371. [Google Scholar] [CrossRef] [PubMed]
[6] Li, Z., Wang, Y. and Sun, H. (2024) The Role of Branched-Chain Amino Acids and Their Metabolism in Cardiovascular Diseases. Journal of Cardiovascular Translational Research, 17, 85-90. [Google Scholar] [CrossRef] [PubMed]
[7] Dimou, A., Tsimihodimos, V. and Bairaktari, E. (2022) The Critical Role of the Branched Chain Amino Acids (BCAAs) Catabolism-Regulating Enzymes, Branched-Chain Aminotransferase (BCAT) and Branched-Chain Α-Keto Acid Dehydrogenase (BCKD), in Human Pathophysiology. International Journal of Molecular Sciences, 23, Article No. 4022. [Google Scholar] [CrossRef] [PubMed]
[8] Nie, C., He, T., Zhang, W., Zhang, G. and Ma, X. (2018) Branched Chain Amino Acids: Beyond Nutrition Metabolism. International Journal of Molecular Sciences, 19, Article No. 954. [Google Scholar] [CrossRef] [PubMed]
[9] Saxton, R.A. and Sabatini, D.M. (2017) mTOR Signaling in Growth, Metabolism, and Disease. Cell, 169, 361-371. [Google Scholar] [CrossRef] [PubMed]
[10] Dalle Pezze, P., Ruf, S., Sonntag, A.G., Langelaar-Makkinje, M., Hall, P., Heberle, A.M., et al. (2016) A Systems Study Reveals Concurrent Activation of AMPK and mTOR by Amino Acids. Nature Communications, 7, Article No. 13254. [Google Scholar] [CrossRef] [PubMed]
[11] Green, C.R., Wallace, M., Divakaruni, A.S., Phillips, S.A., Murphy, A.N., Ciaraldi, T.P., et al. (2015) Branched-Chain Amino Acid Catabolism Fuels Adipocyte Differentiation and Lipogenesis. Nature Chemical Biology, 12, 15-21. [Google Scholar] [CrossRef] [PubMed]
[12] Nicklin, P., Bergman, P., Zhang, B., Triantafellow, E., Wang, H., Nyfeler, B., et al. (2009) Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy. Cell, 136, 521-534. [Google Scholar] [CrossRef] [PubMed]
[13] Wolfson, R.L., Chantranupong, L., Saxton, R.A., Shen, K., Scaria, S.M., Cantor, J.R., et al. (2016) Sestrin2 Is a Leucine Sensor for the Mtorc1 Pathway. Science, 351, 43-48. [Google Scholar] [CrossRef] [PubMed]
[14] Valenstein, M.L., Wranik, M., Lalgudi, P.V., Linde-Garelli, K.Y., Choi, Y., Chivukula, R.R., et al. (2025) Structural Basis for the Dynamic Regulation of Mtorc1 by Amino Acids. Nature, 646, 493-500. [Google Scholar] [CrossRef] [PubMed]
[15] Zhang, D., Contu, R., Latronico, M.V.G., Zhang, J.L., Rizzi, R., Catalucci, D., et al. (2010) MTORC1 Regulates Cardiac Function and Myocyte Survival through 4E-BP1 Inhibition in Mice. Journal of Clinical Investigation, 120, 2805-2816. [Google Scholar] [CrossRef] [PubMed]
[16] Kim, J., Kundu, M., Viollet, B. and Guan, K. (2011) AMPK and mTOR Regulate Autophagy through Direct Phosphorylation of Ulk1. Nature Cell Biology, 13, 132-141. [Google Scholar] [CrossRef] [PubMed]
[17] Sivanand, S. and Vander Heiden, M.G. (2020) Emerging Roles for Branched-Chain Amino Acid Metabolism in Cancer. Cancer Cell, 37, 147-156. [Google Scholar] [CrossRef] [PubMed]
[18] Johnson, W.A., Connelly, J.L. and Glynn, M.T. (1972) Cellular Localization and Characterization of Bovine Liver Branched-Chain Α-Keto Acid Dehydrogenases. Biochemistry, 11, 1967-1973. [Google Scholar] [CrossRef] [PubMed]
[19] Arany, Z. and Neinast, M. (2018) Branched Chain Amino Acids in Metabolic Disease. Current Diabetes Reports, 18, Article No. 76. [Google Scholar] [CrossRef] [PubMed]
[20] Patel, M.S., Nemeria, N.S., Furey, W. and Jordan, F. (2014) The Pyruvate Dehydrogenase Complexes: Structure-Based Function and Regulation. Journal of Biological Chemistry, 289, 16615-16623. [Google Scholar] [CrossRef] [PubMed]
[21] East, M.P., Laitinen, T. and Asquith, C.R.M. (2021) BCKDK: An Emerging Kinase Target for Metabolic Diseases and Cancer. Nature Reviews Drug Discovery, 20, Article No. 498. [Google Scholar] [CrossRef] [PubMed]
[22] Biswas, D., Duffley, L. and Pulinilkunnil, T. (2019) Role of Branched‐Chain Amino Acid-Catabolizing Enzymes in Intertissue Signaling, Metabolic Remodeling, and Energy Homeostasis. The FASEB Journal, 33, 8711-8731. [Google Scholar] [CrossRef] [PubMed]
[23] Mirmiran, P.T.F., Asghari, G. and Azizi, F. (2019) Dietary Intakes of Branched Chain Amino Acids and the Incidence of Hypertension: A Population-Based Prospective Cohort Study. Archives of Iranian Medicine, 22, 182-188.
[24] Flores-Guerrero, J.L., Groothof, D., Connelly, M.A., Otvos, J.D., Bakker, S.J.L. and Dullaart, R.P.F. (2019) Concentration of Branched-Chain Amino Acids Is a Strong Risk Marker for Incident Hypertension. Hypertension, 74, 1428-1435. [Google Scholar] [CrossRef] [PubMed]
[25] Ormazabal, V., Nair, S., Elfeky, O., Aguayo, C., Salomon, C. and Zuñiga, F.A. (2018) Association between Insulin Resistance and the Development of Cardiovascular Disease. Cardiovascular Diabetology, 17, Article No. 122. [Google Scholar] [CrossRef] [PubMed]
[26] Zhao, X., Han, Q., Liu, Y., Sun, C., Gang, X. and Wang, G. (2016) The Relationship between Branched-Chain Amino Acid Related Metabolomic Signature and Insulin Resistance: A Systematic Review. Journal of Diabetes Research, 2016, Article ID: 2794591. [Google Scholar] [CrossRef] [PubMed]
[27] Heusch, G., Libby, P., Gersh, B., Yellon, D., Böhm, M., Lopaschuk, G., et al. (2014) Cardiovascular Remodelling in Coronary Artery Disease and Heart Failure. The Lancet, 383, 1933-1943. [Google Scholar] [CrossRef] [PubMed]
[28] Tobias, D.K., Lawler, P.R., Harada, P.H., Demler, O.V., Ridker, P.M., Manson, J.E., et al. (2018) Circulating Branched-Chain Amino Acids and Incident Cardiovascular Disease in a Prospective Cohort of US Women. Circulation: Genomic and Precision Medicine, 11, e002157. [Google Scholar] [CrossRef] [PubMed]
[29] Bhattacharya, S., Granger, C.B., Craig, D., Haynes, C., Bain, J., Stevens, R.D., et al. (2014) Validation of the Association between a Branched Chain Amino Acid Metabolite Profile and Extremes of Coronary Artery Disease in Patients Referred for Cardiac Catheterization. Atherosclerosis, 232, 191-196. [Google Scholar] [CrossRef] [PubMed]
[30] Zhenyukh, O., Civantos, E., Ruiz-Ortega, M., Sánchez, M.S., Vázquez, C., Peiró, C., et al. (2017) High Concentration of Branched-Chain Amino Acids Promotes Oxidative Stress, Inflammation and Migration of Human Peripheral Blood Mononuclear Cells via mTORC1 Activation. Free Radical Biology and Medicine, 104, 165-177. [Google Scholar] [CrossRef] [PubMed]
[31] Xu, Y., Jiang, H., Li, L., Chen, F., Liu, Y., Zhou, M., et al. (2020) Branched-Chain Amino Acid Catabolism Promotes Thrombosis Risk by Enhancing Tropomodulin-3 Propionylation in Platelets. Circulation, 142, 49-64. [Google Scholar] [CrossRef] [PubMed]
[32] Wang, W., Liu, Z., Liu, L., Han, T., Yang, X. and Sun, C. (2021) Genetic Predisposition to Impaired Metabolism of the Branched Chain Amino Acids, Dietary Intakes, and Risk of Type 2 Diabetes. Genes & Nutrition, 16, Article No. 20. [Google Scholar] [CrossRef] [PubMed]
[33] Lotta, L.A., Scott, R.A., Sharp, S.J., Burgess, S., Luan, J., Tillin, T., et al. (2016) Genetic Predisposition to an Impaired Metabolism of the Branched-Chain Amino Acids and Risk of Type 2 Diabetes: A Mendelian Randomisation Analysis. PLOS Medicine, 13, e1002179. [Google Scholar] [CrossRef] [PubMed]
[34] Satomi, S., Morio, A., Miyoshi, H., Nakamura, R., Tsutsumi, R., Sakaue, H., et al. (2020) Branched-Chain Amino Acids-Induced Cardiac Protection against Ischemia/Reperfusion Injury. Life Sciences, 245, Article ID: 117368. [Google Scholar] [CrossRef] [PubMed]
[35] Wang, W., Zhang, F., Xia, Y., Zhao, S., Yan, W., Wang, H., et al. (2016) Defective Branched Chain Amino Acid Catabolism Contributes to Cardiac Dysfunction and Remodeling Following Myocardial Infarction. American Journal of Physiology-Heart and Circulatory Physiology, 311, H1160-H1169. [Google Scholar] [CrossRef] [PubMed]
[36] Li, Y., Xiong, Z., Yan, W., Gao, E., Cheng, H., Wu, G., et al. (2020) Branched Chain Amino Acids Exacerbate Myocardial Ischemia/Reperfusion Vulnerability via Enhancing GCN2/ATF6/PPAR-α Pathway-Dependent Fatty Acid Oxidation. Theranostics, 10, 5623-5640. [Google Scholar] [CrossRef] [PubMed]
[37] Morio, A., Tsutsumi, R., Kondo, T., Miyoshi, H., Kato, T., Narasaki, S., et al. (2021) Leucine Induces Cardioprotection in Vitro by Promoting Mitochondrial Function via mTOR and Opa-1 Signaling. Nutrition, Metabolism and Cardiovascular Diseases, 31, 2979-2986. [Google Scholar] [CrossRef] [PubMed]
[38] Morio, A., Tsutsumi, R., Satomi, S., Kondo, T., Miyoshi, H., Kato, T., et al. (2021) Leucine Imparts Cardioprotective Effects by Enhancing mTOR Activity and Mitochondrial Fusion in a Myocardial Ischemia/Reperfusion Injury Murine Model. Diabetology & Metabolic Syndrome, 13, Article No. 139. [Google Scholar] [CrossRef] [PubMed]
[39] Cai, C., Guo, Z., Chang, X., Li, Z., Wu, F., He, J., et al. (2022) Empagliflozin Attenuates Cardiac Microvascular Ischemia/Reperfusion through Activating the AMPKα1/ULK1/FUNDC1/Mitophagy Pathway. Redox Biology, 52, Article ID: 102288. [Google Scholar] [CrossRef] [PubMed]
[40] Lopaschuk, G.D., Karwi, Q.G., Tian, R., Wende, A.R. and Abel, E.D. (2021) Cardiac Energy Metabolism in Heart Failure. Circulation Research, 128, 1487-1513. [Google Scholar] [CrossRef] [PubMed]
[41] Da Dalt, L., Cabodevilla, A.G., Goldberg, I.J. and Norata, G.D. (2023) Cardiac Lipid Metabolism, Mitochondrial Function, and Heart Failure. Cardiovascular Research, 119, 1905-1914. [Google Scholar] [CrossRef] [PubMed]
[42] Zaric, B.L., Radovanovic, J.N., Gluvic, Z., Stewart, A.J., Essack, M., Motwalli, O., et al. (2020) Atherosclerosis Linked to Aberrant Amino Acid Metabolism and Immunosuppressive Amino Acid Catabolizing Enzymes. Frontiers in Immunology, 11, Article ID: 551758. [Google Scholar] [CrossRef] [PubMed]
[43] Du, X., You, H., Li, Y., Wang, Y., Hui, P., Qiao, B., et al. (2018) Relationships between Circulating Branched Chain Amino Acid Concentrations and Risk of Adverse Cardiovascular Events in Patients with STEMI Treated with PCI. Scientific Reports, 8, Article No. 15809. [Google Scholar] [CrossRef] [PubMed]
[44] Sun, H., Olson, K.C., Gao, C., Prosdocimo, D.A., Zhou, M., Wang, Z., et al. (2016) Catabolic Defect of Branched-Chain Amino Acids Promotes Heart Failure. Circulation, 133, 2038-2049. [Google Scholar] [CrossRef] [PubMed]
[45] Chen, M., Gao, C., Yu, J., Ren, S., Wang, M., Wynn, R.M., et al. (2019) Therapeutic Effect of Targeting Branched‐Chain Amino Acid Catabolic Flux in Pressure‐Overload Induced Heart Failure. Journal of the American Heart Association, 8, e011625. [Google Scholar] [CrossRef] [PubMed]
[46] Deo, R. and Albert, C.M. (2012) Epidemiology and Genetics of Sudden Cardiac Death. Circulation, 125, 620-637. [Google Scholar] [CrossRef] [PubMed]
[47] Zeppenfeld, K., Tfelt-Hansen, J., de Riva, M., Winkel, B.G., Behr, E.R., Blom, N.A., et al. (2022) 2022 ESC Guidelines for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. European Heart Journal, 43, 3997-4126. [Google Scholar] [CrossRef] [PubMed]
[48] Portero, V., Nicol, T., Podliesna, S., Marchal, G.A., Baartscheer, A., Casini, S., et al. (2021) Chronically Elevated Branched Chain Amino Acid Levels Are Pro-Arrhythmic. Cardiovascular Research, 118, 1742-1757. [Google Scholar] [CrossRef] [PubMed]
[49] Yu, L., Dong, X., Zhao, J., Xu, Y., Xu, D., Xue, X., et al. (2022) Activation of PKG-CREB-KLF15 by Melatonin Attenuates Angiotensin II-Induced Vulnerability to Atrial Fibrillation via Enhancing Branched-Chain Amino Acids Catabolism. Free Radical Biology and Medicine, 178, 202-214. [Google Scholar] [CrossRef] [PubMed]
[50] Gong, H., Jin, L., Zhang, Y., Gong, L., Wang, Y., Liu, P., et al. (2025) Swim Exercise Mitigates BCAA‐Induced Atrial Remodeling and AF Susceptibility via Inhibition of Bax‐Mediated Mitochondrial Apoptosis. The FASEB Journal, 39, e71227. [Google Scholar] [CrossRef
[51] Li, T., Zhang, Z., Kolwicz, S.C., Abell, L., Roe, N.D., Kim, M., et al. (2017) Defective Branched-Chain Amino Acid Catabolism Disrupts Glucose Metabolism and Sensitizes the Heart to Ischemia-Reperfusion Injury. Cell Metabolism, 25, 374-385. [Google Scholar] [CrossRef] [PubMed]
[52] White, P.J. and Newgard, C.B. (2019) Branched-Chain Amino Acids in Disease. Science, 363, 582-583. [Google Scholar] [CrossRef] [PubMed]
[53] Iliou, A., Mikros, E., Karaman, I., Elliott, F., Griffin, J.L., Tzoulaki, I., et al. (2021) Metabolic Phenotyping and Cardiovascular Disease: An Overview of Evidence from Epidemiological Settings. Heart, 107, 1123-1129. [Google Scholar] [CrossRef] [PubMed]
[54] White, P.J., McGarrah, R.W., Herman, M.A., Bain, J.R., Shah, S.H. and Newgard, C.B. (2021) Insulin Action, Type 2 Diabetes, and Branched-Chain Amino Acids: A Two-Way Street. Molecular Metabolism, 52, Article ID: 101261. [Google Scholar] [CrossRef] [PubMed]